Zynex(US:ZYXI) Globenewswire·2026-03-06 21:00Core Viewpoint - Zynex, Inc. is facing a class action lawsuit due to allegations of issuing false and misleading statements, resulting in inflated revenue and fraudulent overbilling practices [3][4]. Allegations - The complaint alleges that Zynex shipped products in excess of need, leading to inflated revenue [3]. - The company is accused of filing false claims that drew scrutiny from insurers, including Tricare [3]. - Travelers initiated legal action against Zynex and its executives, seeking over $23 million in damages related to fraudulent claims from 2018 to 2023 [3]. - Management prioritized aggressive sales strategies over compliance with industry regulations [3]. - The company allegedly lacked a commitment to maintaining a strong internal control environment [3]. - Order growth was reportedly a result of illegal overbilling practices [3]. - There is a reasonable likelihood of adverse consequences for Zynex, including removal from insurer networks and federal penalties [3]. - Positive statements made by the defendants regarding the company's business were materially misleading [3]. Legal Proceedings - Shareholders who purchased ZYXIQ shares between February 25, 2021, and December 15, 2025, are encouraged to register for the class action [4]. - The deadline for shareholders to seek lead plaintiff status is April 21, 2026 [4]. - Registered shareholders will receive updates throughout the case lifecycle [4]. Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements [5].